A gene shared by salamanders, zebrafish and mice could point toward a new path for regenerative medicine: researchers have identified key genetic programs involved in regrowth and used them to partially restore digit regeneration in mice. The findings do not bring human limb regeneration within immediate reach, but they offer a promising proof of principle for future gene-based therapies.

Researchers at McMaster University have developed a new generative artificial intelligence (AI) model capable of drastically speeding up drug discovery — and, in early tests, it has already designed a brand-new antibiotic.

Hantavirus, transmitted from rodents to humans is one of the highest concerns for future pandemics. Researchers have produced a detailed blue print of a protein complex that the Ande Virus uses to infect the host cells. This move will help design effective vaccines and antibody therapies against the deadly Hantavirus.

A new algae-based biochar material could offer a breakthrough in tackling PFAS pollution. Researchers report that a photocatalytic nanoreactor made from marine algae removes more than 97 percent of the toxic “forever chemical” PFOA from water, combining high efficiency, reusability, and easy recovery with a sustainable biomass-based design.

Researchers from the USA are spearheading a project to test whether reducing DNA-triggered inflammation can help older adults stay healthier for longer. The federal Advanced Research Projects Agency for Health has also awarded 22 million dollars to the project.

In a new study, researchers have integrated data from all three types of genetic testing to create a 360-degree view of disease risk. Their approach identifies rare mutations, evaluates cumulative genetic influences and uncovers hidden patterns in the full genome.

Children, older adults and people who spend most of their time indoors may face elevated health risks from unseen household contaminants. Researchers now warn that modern buildings can trap and transform chemicals in ways that amplify long-term exposure.

The authors of a recent paper have revealed that changing the consumption-driven nature of our food systems would significantly benefit public health and the climate.

With a massive investment of 2 billion dollars, Astrazeneca has plans to expand its manufacturing footprint in Maryland, USA. This includes a significant expansion of its flagship biologics manufacturing facility in Frederick and construction of a new state-of-the-art facility in Gaithersburg for the development and clinical supply of innovative molecules to be used in clinical trials.

Researchers at the University of Pennsylvania have discovered a way to make mRNA vaccines safer and more effective — by adding anti-inflammatory molecules inspired by olive oil. Their new lipid design not only reduces side effects like soreness and fatigue but also boosts vaccine performance against diseases like Covid-19 and cancer.